Expression and function of DMT1 without IRE in C6 cells mediated by recombinant adenovirus

doi:10.1007/s11684-009-0010-0

Front Med Chin

2009, Vol. 3

Issue (1) : 67-71 https://doi.org/10.1007/s11684-009-0010-0

RESEARCH ARTICLE

Expression and function of DMT1 without IRE in C6 cells mediated by recombinant adenovirus

Xixun DU*, Huamin XU*, Hong JIANG, Jun WANG, Lei WANG, Junxia XIE(

)

State Key Disciplines: Physiology(in incubation), Department of Physiology, Medical College of Qingdao University, Qingdao 266071, China

Download: PDF(137 KB) HTML
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks

Abstract

Divalent metal transporter 1 (DMT1) is a ferrous iron import protein. The improper expression of DMT1 is involved in neurodegenerative diseases. In the present study, we constructed a recombinant adenovirus containing the gene of DMT1 without the iron response element (DMT1-IRE) and investigated its expression and function in the C6 glioma cell line. The DMT1-IRE gene, obtained by RT-PCR, was cloned into the shuttle plasmid pAdTrack-CMV containing green fluorescent protein (GFP) reporter gene. Linearized plasmid pAdTrack-CMV-DMT1-IRE was subsequently co-transformed into Escherichia coli (E. coli) BJ5183 cells along with an adenoviral backbone plasmid pAdEasy-1 after digestion with Pme I. Pac I-digested pAdEasy1-DMT1-IRE was then transfected into E1-transformed human embryonic kidney cells (HEK293 cells) , in which recombinant adenoviruses were generated within 7 to 10 days. The results demonstrated that we obtained the DMT1-IRE gene. pAdEasy1-DMT1-IRE yielded a large fragment, plus a smaller fragment of 4.5 kb after digestion with PacI. PCR confirmed pAdEasy1-DMT1-IRE contained gene DMT1-IRE, indicating the successful construction of recombinant adenovirus plasmid containing DMT1-IRE. GFP fluorescence further confirmed the generation of adenovirus. AdDMT1-IRE could efficiently infect C6 glioma cells. And cell viability decreased in Ad-DMT1-IRE infected cells after iron overload compared to the control. These results suggest that the over expressed DMT1-IRE can aggravate the iron induced cell death due to its iron influx function.

Keywords divalent metal transporter 1 recombinant adenovirus homologous recombination iron

Corresponding Author(s): XIE Junxia,Email:jxiaxie@public.qd.sd.cn

Issue Date: 05 March 2009

Cite this article:

Xixun DU*,Huamin XU*,Hong JIANG, et al. Expression and function of DMT1 without IRE in C6 cells mediated by recombinant adenovirus[J]. Front Med Chin, 2009, 3(1): 67-71.

URL:

https://academic.hep.com.cn/fmd/EN/10.1007/s11684-009-0010-0
https://academic.hep.com.cn/fmd/EN/Y2009/V3/I1/67

Fig.1 Construction of recombinant adenovirus plasmid encoding DMT1-IRE. (a) RT-PCR for the human DMT1-IRE gene. Human full-length cDNA of DMT1-IRE was isolated by RT-PCR. (b) Double digestive maps of plasmid pMD18-T-DMT1-IRE with I and d III. (c) Double digestive maps of plasmid pAdCMV-DMT1-IRE with I and d III. (d) Restrictive enzyme analysis of pAdDMT1-IRE from clones with I. Candidate clone pAdDMT1-IRE yielded a large fragment, plus a smaller fragment of 4.5 kb. DMT1: divalent metal transporter 1; IRE: iron response element.

Fig.2 GFP fluorescence expression monitored by confocal. Linearized pAdEasy1-DMT1-IRE was transfected into HEK293 cells with lipofectamine 2000 and cells were harvested at the indicated time after transfection. Fluorescence microscopy of the infected cells was performed. (a) GFP fluorescence after 48 hours; (b) GFP fluorescence after 6 days.

Fig.3 The mRNA expression of DMT1-IRE in AdDMT1-IRE infected C6 cells. The mRNA levels of DMT1-IRE were observed by RT-PCR after infection for 36 hours. DMT1-IRE mRNA expression increased significantly after AdDMT1-IRE infection compared with the control in C6 cells. : <0.01 compared with control.

Fig.4 Cell viability detected by MTT. After exposure to ferrous iron for 24 hours, cells infected with AdDMT1-IRE induced a significant decrease in cell viability compared with the control after iron incubation. : <0.01 compared with control.

1	Karlin K D. Metalloenzymes, structural motifs, and inorganic models. Science , 1993, 261(5122): 701-708 doi: 10.1126/science.7688141
2	Aisen P. Iron metabolism: An evolutionary perspective. In: Brock J H, Halliday J W, Powell L W, eds. Iron metabolism in health and disease . London: Saunders WB, 1994, 1-30
3	Jellinger K, Paulus W, Grundke-Iqbal I, Riederer P, Youdim M B. Brain iron and ferritin in Parkinson’s and Alzheimer’s diseases. J Neural Transm Park Dis Dement Sect , 1990, 2(4): 327-340 doi: 10.1007/BF02252926
4	Grunheid S, Cellier M, Vidal S, Gros P. Identification and characterization of a second mouse Nramp gene. Genomics , 1995, 25(2): 514-525 doi: 10.1016/0888-7543(95)80053-O
5	Gunshin H, Mackenzie B, Berger U V, Gunshin Y, Romero M F, Boron W F, Nussberger S, Gollan J L, Hediger M A. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature , 1997, 388(6641): 482-488 doi: 10.1038/41343
6	Fleming M D, Trenor C C 3rd, Su M A, Foernzler D, Beier D R, Dietrich W F, Andrews N C. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet , 1997, 16(4): 383-386
7	Canonne H F, Gruenheid S, Ponka P, Gros P. Cellular and subcellular localization of the Nramp2 iron transporter in the intestinal brush border and regulation by dietary iron. Blood , 1999, 93(12): 4406-4417
8	Huang E, Ong W Y, Connor J R. Distribution of divalent metal transporter-1 in the monkey basal ganglia. Neuroscience , 2004, 128(3): 487-496 doi: 10.1016/j.neuroscience.2004.06.055
9	Andrews N C, Fleming M D, Gunshin H. Iron transport across biological membranes. Nutr Rev , 1999, 57(4): 114-123
10	Jiang H, Qian Z M, Xie J X. The increased DMT1 expression and iron content in MPTP-treated C57BL/6 mice. Acta Physiologica Sinica , 2003, 55(5): 571-576
11	Atasoy H T, Nuyan O, Tunc T, Yorubulut M, Unal A E, Inan L E. T2-weighted MRI in Parkinson's disease; substantia nigra pars compacta hypointensity correlates with the clinical scores. Neurol India , 2004, 52(3): 332-337
12	Gerlach M, Double K L, Youdim M B, Riederer P. Potential sources of increased iron in the substantia nigra of parkinsonian patients. J Neural Transm Suppl , 2006, (70): 133-142 doi: 10.1007/978-3-211-45295-0_21
13	Fleming M D, Romano M A, Su M A, Garrick L M, Garrick M D, Andrews N C. Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport. Proc Natl Acad Sci U S A , 1998, 95(3): 1148-1153 doi: 10.1073/pnas.95.3.1148
14	Su M A, Trenor C C, Fleming J C, Fleming M D, Andrews N C. The G185R mutation disrupts function of iron transporter Nramp2. Blood , 1998, 92(6): 2157-2163
15	Burdo J R, Menzies S L, Simpson I A, Garrick L M, Garrick M D, Dolan K G, Haile D J, Beard J L, Connor J R. Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat. J Neurosci Res , 2001, 66(6): 1198-1207 doi: 10.1002/jnr.1256
16	Wesley R D, Tang M, Lager K M. Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus. Vaccine , 2004, 22(25-26): 3427-3434 doi: 10.1016/j.vaccine.2004.02.040
17	Chinsangaram J, Moraes M P, Koster M, Grubman M J. Novel viral disease control strategy: adenovirus expressing alpha interferon rapidly protects swine from foot-and-mouth disease. J Virol , 2003, 77(2): 1621-1625 doi: 10.1128/JVI.77.2.1621-1625.2003
18	Mascola J R, Sambor A, Beaudry K, Santra S, Welcher B, Louder M K, Vancott T C, Huang Y, Chakrabarti B K, Kong W P, Yang Z Y, Xu L, Montefiori D C, Nabel G J, Letvin N L. Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteins. J Virol , 2005, 79(2): 771-779 doi: 10.1128/JVI.79.2.771-779.2005
19	Martin F S, Heike O, Heinz S. Transfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: Crossing the species barrier. J Virol , 2001, 75(11): 5108-5118 doi: 10.1128/JVI.75.11.5108-5118.2001

[1]	Minhong Shen, Yibin Kang. Complex interplay between tumor microenvironment and cancer therapy[J]. Front. Med., 2018, 12(4): 426-439.
[2]	Alexandra Urman,H. Dean Hosgood. Curbing the burden of lung cancer[J]. Front. Med., 2016, 10(2): 228-232.
[3]	Yi Cao. Environmental pollution and DNA methylation: carcinogenesis, clinical significance, and practical applications[J]. Front. Med., 2015, 9(3): 261-274.
[4]	Qiang Gao, Yinghong Shi, Xiaoying Wang, Jian Zhou, Shuangjian Qiu, Jia Fan. Translational medicine in hepatocellular carcinoma[J]. Front Med, 2012, 6(2): 122-133.
[5]	Liangqian Tong, Ming Zhao, Shu Zhu, Jing Chen. Synthesis and application of superparamagnetic iron oxide nanoparticles in targeted therapy and imaging of cancer[J]. Front Med, 2011, 5(4): 379-387.
[6]	Linda S. BIRNBAUM PhD, DABT, ATS, . Cancer and the environment: Filling knowledge gaps together[J]. Front. Med., 2010, 4(2): 131-133.
[7]	Hui QIU, Hui ZHANG, Zuohua FENG. 4-1BBL expressed by eukaryotic cells activates immune cells and suppresses the progression of murine tumor[J]. Front Med Chin, 2009, 3(1): 20-25.
[8]	JIN Qiumei, LI Yan, SUN Zengrong. Estrogenic activities of di-2-ethylhexyl phthalate[J]. Front. Med., 2008, 2(3): 303-308.
[9]	XU Qingwen, CHEN Weifeng. Developing effective tumor vaccines: basis, challenges and perspectives[J]. Front. Med., 2007, 1(1): 11-19.

Viewed

Full text

Abstract

Cited

Shared

Discussed